Quartesian Shattered Records in 2016

As pharmaceutical and biotech innovations continue to gather speed, the clinical research industry demands better models for producing high quality data. Quartesian serves these markets at the intersection of quality, speed, and cost efficiency — whether we’re helping generics gain an edge in the race to file first or providing CROs with high quality clinical data management and statistical programming.

That’s why it’s no surprise that Quartesian posted record results for 2016, with a 61% increase in YOY revenue and the addition of 13 new clients, including two of the world’s top five CROs and three top-five generics companies. We’re honored to serve more than one hundred clients with the commitment and expertise that keeps them coming back, and look forward to more record-breaking years delivering Clinical Data Your Way.

For more information on Quartesian’s record-breaking year, along with comments from CEO Benjamin Jackson, read our press release — then follow us @Quartesian for more news and updates.

Contact us